Digital Health in Japan and Korea – Where Is It Heading?

Opportunities and Challenges for Drug Makers in MDD

Rise of Innovative Medtech in APAC

AAOS 2022: The Latest Ortho Insights

Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases

Women’s Health at Home: Reflections on a Rapidly Growing Space

Building and Defending Markets; Reflections on Attending DTx and NASS Conferences

Resurgence in Drug Development for Renal Diseases

AI in Healthcare: Insights from Two Decades of FDA Approvals

Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better?

India, the Generic Manufacturing Powerhouse, Biosimilar Next?

Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?

Google Has Officially Acquired Fitbit. Now What?

When Off-Label is Your Biggest Competition: Rituximab in Autoimmune Diseases

How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen

Hong Kong Exchange: Nurturing China’s Biotech Valley

Biopharma R&D in the Post-COVID World

eBook: Biopharma in the COVID-19 World

Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

Value Creation in Molecular Diagnostics: A Game of Luck or Skill?

Health Advances Blog

Author: healthadvances

Digital Health in Japan and Korea – Where Is It Heading?

Opportunities and Challenges for Drug Makers in MDD

Rise of Innovative Medtech in APAC

AAOS 2022: The Latest Ortho Insights

Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases

Women’s Health at Home: Reflections on a Rapidly Growing Space

Building and Defending Markets; Reflections on Attending DTx and NASS Conferences

Resurgence in Drug Development for Renal Diseases

AI in Healthcare: Insights from Two Decades of FDA Approvals

Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better?

India, the Generic Manufacturing Powerhouse, Biosimilar Next?

Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?

Google Has Officially Acquired Fitbit. Now What?

When Off-Label is Your Biggest Competition: Rituximab in Autoimmune Diseases

How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen

Hong Kong Exchange: Nurturing China’s Biotech Valley

Biopharma R&D in the Post-COVID World

eBook: Biopharma in the COVID-19 World

Against All Odds: Can Covid-19 Usher in a New Era in International Public Health Cooperation?

Value Creation in Molecular Diagnostics: A Game of Luck or Skill?